Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 September, 2018 12:51 IST
Zydus receives final approval from USFDA for Zolmitriptan tablets
Source: IRIS | 12 Jul, 2018, 10.37AM
Comments  |  Post Comment

Zydus Cadila has received the final approval from the USFDA to market Zolmitriptan Tablets, 2.5 mg and 5 mg. It is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting and sensitivity to light/sound). It will be manufactured at the group's manufacturing facility at Moraiya, Ahmedabad.

In line with this, the group now has 203 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.

Shares of the company declined Rs 2.55, or 0.69%, to trade at Rs 368.95. The total volume of shares traded was 37,256 at the BSE (10.24 a.m., Thursday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Glenmark Pharma inducted into DJSI Emerging Market 2018 - 19-Sep-2018 12:09
Rites bags additional contract worth Rs 4.36 bn from Indian Railways - 19-Sep-2018 12:00
TVS Motor Company strengthens its presence in Mexico - 19-Sep-2018 11:56
Himachal Futuristic Communications bags order worth Rs 6.11 bn - 19-Sep-2018 11:52
Tata Steel completes acquisition of Creative Port Development - 19-Sep-2018 11:48
SABIC acquires 24.99% stake in Clariant globally - 19-Sep-2018 11:45
Tata Power launches its VoiceBOT TINA - 19-Sep-2018 11:42
Sun Pharma gets European Commission nod for ILUMETRI - 18-Sep-2018 17:02
Indian Hume Pipe receives LoA for order worth Rs 2.21 bn - 18-Sep-2018 16:58
ICICI Prudential Life and Saraswat Co-operative Bank sign bancassurance partnership - 18-Sep-2018 16:51
Tata iQ selects TCS Jile to Drive Agile Transformation - 18-Sep-2018 16:48
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer